Aim Cardiac rhabdomyoma, known as the most common benign cardiac tumor in
childhood, is strongly associated with tuberous sclerosis complex. This study
aims to present our single-center experience regarding clinical observations,
diagnostic approaches, and treatment modalities for cardiac rhabdomyoma
identified during the neonatal period.
Patients and Methods In this clinical observational study, we
retrospectively assessed the outcomes of 12 newborn patients diagnosed with
cardiac rhabdomyoma who were followed up in our neonatal intensive care unit
over the past 12 years.
Results The mean gestational age of the patients was 38.2±1.6 weeks, with
an average birth weight of 3193±314 grams. The mean postnatal age at initial
diagnosis was 12.42±15.75 days. Tuberous sclerosis complex was clinically
identified in 50% of cases (six patients). Seven infants received everolimus
treatment, while three infants underwent clinical monitoring without specific
interventions. A significant reduction in cardiac mass size was observed in all
surviving patients, leading to their subsequent discharge from the hospital.
Conclusion Cardiac rhabdomyomas often undergo spontaneous regression in
early childhood. However, in cases with obstructive lesions or arrhythmias, they
may present life-threatening consequences. Timely diagnosis, appropriate
clinical management, and monitoring are crucial in optimizing outcomes for
neonates with cardiac rhabdomyoma.